Comparison of the analgesic effect of diclofenac suppositories and ketorolac ampoules immediately after cesarean section under general anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240812062729N1

Enrollment

Registered

2024-08-21

Start date

2024-09-20

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after surgery. Acute pain

Interventions

Intervention 1: Intervention group: After cesarean section, Ketorolac 30 mg intravenously (ketorolac 30 mg/ml intravenous ampoule - Zahravi Pharmaceuticals). Intervention 2: Intervention group: Diclof

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing cesarean section Receive general anesthesia

Exclusion criteria

Exclusion criteria: Lack of consent to participate in the study Age below 18 years

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1, 6, 12 and 24 hours after surgery. Method of measurement: Pain is evaluated by VAS scale during 1, 6, 12 and 24 hours after surgery.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Giveh Ki

Islamic Azad University

drgiveki@gmail.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026